DaShenLin Pharmaceutical Group Co., Ltd.'s (SHSE:603233) Market Cap Increased by CN¥649m, Insiders Receive a 65% Cut

Simply Wall StDec 13, 2024 17:39 ET

Is DaShenLin Pharmaceutical Group Co., Ltd.'s (SHSE:603233) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Simply Wall StNov 25, 2024 18:18 ET

DaShenLin Pharmaceutical Group Co., Ltd. (SHSE:603233) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

Simply Wall StOct 20, 2024 20:10 ET

DaShenLin Pharmaceutical Group (SHSE:603233) Stock Falls 11% in Past Week as Three-year Earnings and Shareholder Returns Continue Downward Trend

Simply Wall StOct 12, 2024 22:21 ET

Cautious Investors Not Rewarding DaShenLin Pharmaceutical Group Co., Ltd.'s (SHSE:603233) Performance Completely

Simply Wall StSep 25, 2024 02:52 ET

DaShenLin Pharmaceutical Group's (SHSE:603233) Conservative Accounting Might Explain Soft Earnings

Simply Wall StSep 6, 2024 18:33 ET